Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) Director Jack Wyszomierski sold 3,925 shares of Exelixis stock in a transaction on Monday, June 1st. The shares were sold at an average price of $50.55, for a total transaction of $198,408.75. Following the completion of the transaction, the director directly owned 284,384 shares of the company’s stock, […]

Qorvo, Inc. (NASDAQ:QRVO – Get Free Report) Director Peter Feld sold 1,900,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $101.20, for a total value of $192,280,000.00. Following the transaction, the director directly owned 5,611,526 shares in the company, valued […]

Columbia Sportswear Company (NASDAQ:COLM – Get Free Report) Director Stephen Babson sold 4,150 shares of the stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $67.95, for a total value of $281,992.50. Following the sale, the director owned 132,376 shares of the company’s stock, valued […]

Evergy Inc. (NASDAQ:EVRG – Get Free Report) Director Sandra Aj Lawrence sold 400 shares of Evergy stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $82.04, for a total transaction of $32,816.00. Following the sale, the director directly owned 1,280 shares of the company’s stock, valued at […]

SiBone (NASDAQ:SIBN – Get Free Report) Director Timothy Davis, Jr. sold 3,500 shares of the firm’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $14.14, for a total value of $49,490.00. Following the transaction, the director owned 65,722 shares in the company, valued at approximately $929,309.08. […]

Applied Materials, Inc. (NASDAQ:AMAT – Get Free Report) Director Judy Bruner sold 1,128 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $450.00, for a total transaction of $507,600.00. Following the completion of the transaction, the director directly owned 26,544 shares in the […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 87,425 shares of the business’s stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $0.45, for a total transaction of $39,341.25. Following the transaction, the director directly owned 831,635 shares of the company’s […]